Search

everythinglearnresearchcommunity

for

Search:↓

Mood stabilizers like lithium and anticonvulsants have side effects that can lead to patients stopping their medication, and managing these effects is important for treatment adherence.

Neurosteroids show promise for treating epilepsy and more research is needed.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

Brain-Derived Neurotrophic Factor (BDNF) slows down hair growth and promotes hair follicle regression.

Some psychiatric medications can cause hair loss, but it usually grows back after adjusting the medication.

Androgens are important for normal ovarian function and estrogen production, but may not be the main cause of follicle death.

LED therapy is safe and shows potential for treating skin conditions and promoting hair growth, but more research is needed.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

Notch-related genes play a key role in the development and cycling of hair follicles.

The study showed that hair follicle stem cells can maintain and organize themselves in a lab setting, keeping their ability to renew and form hair and skin.

Finasteride affects brain and blood steroids, causing lasting sexual and emotional side effects.

Most patients with chronic kidney disease have skin problems, which get worse as the disease progresses, and dialysis doesn't greatly reduce these issues.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

Certain signals and genes play a key role in hair growth and regeneration, and understanding these could lead to new treatments for skin regeneration.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

A position effect on the TRPS1 gene causes excessive hair growth in humans and mice.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

Both drugs lower DHT levels, with GI198745 being more effective.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Wnt signaling may be linked to heart diseases in aging and could be a target for future treatments.

Genetics and hormones cause hair loss; finasteride treats it safely.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

Improving the environment and cell interactions is key for creating human hair in the lab.

Finasteride helps reduce priapism in sickle cell anemia patients.

Baldness caused by male hormones in female-to-male transsexuals doesn't increase the risk of heart disease.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Patients with Bohring-Opitz syndrome and ASXL1 mutations need regular kidney ultrasounds to check for tumors.

The document suggests treating individuals with nonclassic congenital adrenal hyperplasia who show symptoms, especially those related to excess male hormones.